Tuck, are you still following this company?
Dr. Rosenthal only stayed a little over a year.
Boston Life Sciences Announces Departure of Chief Executive Officer
Monday September 22, 7:01 pm ET
BOSTON--(BUSINESS WIRE)--Sept. 22, 2003--Boston Life Sciences, Inc. (NASDAQ:BLSI - News) has announced that it has accepted, with regret, the resignation of its President and Chief Executive Officer, Dr. Robert J. Rosenthal. The Company's Chairman, David Hillson, commented "Bob brought us a high level of the skills required to move BLSI through its transition from an early stage research and development company to a multi-product development entity. We are sorry to lose his considerable talent and experience and wish him great success in his new business venture. Bob will be available to assist the Company in effecting a smooth transition. We intend to appoint, as President and Chief Executive Officer, another senior level executive with hands-on biotech/pharmaceutical experience, and will launch an industry-wide search promptly. We will stress a career history that prominently features regulatory, FDA, and clinical development exposure. We hope to provide specific elaboration on this and other potential executive additions following our Board meeting this Thursday, September 25, 2003." |
